Big news with positive result announced for a randomized study of a GLP-1 agonist for Parkinson's just released NEJM. A new era for Parkinson's or alternatively, more questions than answers raised by Meissner and colleagues.
Key Points:
- This multi-center French trial studied…

Just published. thelancet.com/journals/ebiom…

I’ve had some Qs from future #MovementDisorders fellows recently regarding the decision of where to train for fellowship. Here are 5 basic considerations 🧵:

1. Location. 🗺️
Consider whether any geographic limitations exist for you to narrow down your options

'we use models to understand the causal processes in our world and race is a very poor causal model for genetics'...A very illustrative thread about misconceptions and methodological limits of genetic ancestry estimations in large genetic studies

What is the phenoconversion rate per year in pure autonomic failure (PAF) to synucleinopathy? ~12% according to a new multicenter prospective longitudinal cohort just published by Patricio Millar Vernetti and Horacio Kaufmann in Brain. This paper will be 'seminal' and is…

Many thanks to ⁦Dawn Skirpan⁩ and ⁦Luca Marsili, MD⁩ for presenting updates on the #CCBP infrastructure and data. I’m proud of the team and of the students behind the 2nd annual Parkinson’s Together event for patients and caregivers in Cincinnati. parkinsonstogether.us

#MDSPAS final day comes with an everlasting reflection from brilliant Abhishek Lenka: the only constant in the world is change. Phenomenal talk!

So far, the best talk of #MDSPAS2024 👏. You rock Joaquin Vizcarra
MDS

Glad you liked it!

Dr. Joaquin Vizcarra Joaquin Vizcarra University of Pennsylvania Neurology covers the ever-evolving and increasingly interesting topic of AI in Movement disorders.

The brilliant Joaquin Vizcarra giving a talk about AI in Movement disorders at #MDSPAS2024 MDS

Fantastic ❤️ #pascongress #AI MDS Mayela R. Violante Joaquin Vizcarra Catalina Cerquera-Cleves

The session about Artificial Intelligence and technology in movement disorders has been one of my favorites in this MDS #MDSPAS2024 meeting! Amazing job by Joaquin Vizcarra Mayela R. Violante and Catalina Cerquera-Cleves

Potential AI applications for predicting gait freezing and treatment response in #Parkinsons , just reviewed by ⁦Joaquin Vizcarra⁩. He is also dreaming of a future closed-loop levodopa delivery system and taking the PD Diary to the next level ⁦MDS⁩ #pascongress

Our own Dr. Luca Marsili, MD presenting his fascinating work on Mona Lisa’s smile MUSC Neurology

Animal models have been used to gain pathophysiologic insights and aid in translational efforts to guide human clinical trials in PD.

This effort with current, former University of Cincinnati researchers and collaborators presents a clinician’s perspective.

Full text: mdpi.com/2076-3425/14/2…

Honored to participate in this important discussion, and looking forward to sharing the session with Joaquin Vizcarra and Mayela R. Violante !

#ArtificialIntelligence #MovementDisorders #ParkinsonDisease
#NeuroTwitter

On February 10th, in beautiful Cartagena, we will dive into the world of #ArtificialInteligence and Movement Disorders. Don't miss Session 2104 at #PASCongress , with Mayela R. Violante and Catalina Cerquera-Cleves!

The number of movement disorders fellowship positions offered through SF Match has almost doubled over the last decade and ~ 60 neurology residents start training in movement disorders in July every year.

Looking forward to the 2024 fellowship applications in 2 months.

Finally at the end of training and planning to apply/ interviewing for academic jobs?

Our article on the forest and the trees of an academic job search is finally out Neurology Journal. Includes approach for IMGs.

P.S. Supplementary data

Link: neurology.org/doi/pdf/10.121…